Pacira Biosciences earnings were -$103.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest PCRX earnings report on Mar 31, 2025 announced Q1 2025 earnings of $4.8M, down 70% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PCRX reported annual earnings of -$99.6M, with -337.3% growth. The next PCRX earnings date is Aug 5, 2025.
What were Pacira Biosciences's earnings last quarter?
On PCRX's earnings call on Invalid Date, Pacira Biosciences (NASDAQ: PCRX) reported Q1 2025 earnings per share (EPS) of $0.10, up 47.37% year over year. Total PCRX earnings for the quarter were $4.81 million. In the same quarter last year, Pacira Biosciences's earnings per share (EPS) was $0.19.
The next PCRX earnings call is Invalid Date. Add PCRX to your watchlist to be reminded of Pacira Biosciences's next earnings date.
Is Pacira Biosciences profitable or losing money?
As of the last Pacira Biosciences earnings report, Pacira Biosciences is currently losing money. Pacira Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$103.73 million, a 247.19% decrease year over year.
What was PCRX's earnings growth in the past year?
As of Pacira Biosciences's earnings date in Invalid Date, Pacira Biosciences's earnings has grown year over year. PCRX earnings in the past year totalled -$103.73 million.
What are Pacira Biosciences's earnings expectations?
The current EPS estimate for Pacira Biosciences's earnings report in Invalid Date is $0.68.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.